Faculty of Engineering, Genetics and Bioengineering Department, Yeditepe University, Istanbul, Turkey.
Biotechnology Research Laboratory, Center of Excellence in Biomaterials and Tissue Engineering, BIOMATEN, METU, Ankara, Turkey.
Adv Exp Med Biol. 2018;1119:85-101. doi: 10.1007/5584_2018_253.
Gene therapy provides a promising approach for regeneration and repair of injured bone. Application of gene therapy has displayed increased efficiency in various animal models and preclinical trials in comparison with traditional bone grafting methods. The objective of this review is to highlight fundamental principles of gene therapy strategies in bone tissue engineering and solutions of their current limitations for the healing of bone injury. Vector types are debated for the repair of defected site due to demonstration of constraints and applications of the protocols. In recent years, the combination of gene therapy strategies and bone tissue engineering has highly gained attention. We discussed viral and non-viral mediated delivery of therapeutic protein by using scaffolds for bone tissue engineering. Although pre-clinical studies have showed that gene therapy has very promising results to heal injured bone, there are several limitations regarding with the usage of gene delivery methods into clinical applications. Choice of suitable vector, selection of transgene and gene delivery protocols are the most outstanding questions. This article also addresses current state of gene delivery strategies in bone tissue engineering for their potential applications in clinical considerations.
基因治疗为受损骨骼的再生和修复提供了一种很有前途的方法。与传统的骨移植方法相比,基因治疗在各种动物模型和临床前试验中的应用显示出了更高的效率。本文的目的是强调基因治疗策略在骨组织工程中的基本原则,以及为解决其在骨损伤愈合方面的当前局限性而提出的解决方案。由于各种方案的局限性和应用的限制,载体类型一直是修复缺陷部位的争议焦点。近年来,基因治疗策略与骨组织工程的结合受到了高度关注。我们讨论了通过支架进行的治疗性蛋白的病毒和非病毒介导的传递在骨组织工程中的应用。尽管临床前研究表明,基因治疗在治疗受损骨骼方面具有非常有前景的结果,但在将基因传递方法应用于临床实践方面仍存在一些限制。合适载体的选择、转基因的选择和基因传递方案是最突出的问题。本文还讨论了骨组织工程中基因传递策略的现状,以及它们在临床考虑中的潜在应用。